Disease management programme for secondary prevention of coronary heart disease and heart failure in primary care: A cluster randomised controlled trial

Heart

Volumn 93, Issue 11, 2007, Pages 1398-1405

  Khunti, Kamlesh ^a   Stone, Margaret ^a   Paul, Sanjoy ^b   Baines, Jan ^a   Gisborne, Louise ^a   Farooqi, Azhar ^a   Luan, Xiujie ^a   Squire, Iain ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ANTILIPEMIC AGENT; CHOLESTEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; UNITED KINGDOM; BLOOD; BLOOD PRESSURE; CORONARY ARTERY DISEASE; DISEASE MANAGEMENT; DRUG UTILIZATION; ECHOGRAPHY; HEART LEFT VENTRICLE FUNCTION; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; RISK FACTOR; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTILIPEMIC AGENTS; BLOOD PRESSURE; CHOLESTEROL; CORONARY DISEASE; DISEASE MANAGEMENT; DRUG UTILIZATION; ENGLAND; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; QUALITY OF LIFE; RISK FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 38449122799     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2006.106955     Document Type: Article

References (43)

1. Sans S, Kesteloot H, Kromhout D. The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J 1997;18:1231-48.
2. Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation 2004;109:1101-7.
3. Ergin A, Muntner P, Sherwin R, et al. Secular trends in cardiovascular disease mortality, incidence, and case fatality rates in adults in the United States. Am J Med 2004;117:219-27.
4. EUROSPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J 2001;22:554-72.
5. Campbell NC, Thain J, Deans HG, et al. Secondary prevention in coronary heart disease: baseline survey of provision in general practice. BMJ 1998;316:1430-4.
6. Moher M, Yudkin P, Wright L, et al. Cluster randomised controlled trial to compare three methods or promoting secondary prevention of coronary heart disease in primary care. BMJ 2001;322:1338-42.
7. McMurray JJ, Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart (British Cardiac Society) 2000;83:590-602.
8. Stewart S, MacIntyre K, Hole DJ, et al. More 'malignant' than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail 2001;3:315-22.
9. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-7.
10. Flather MD, Yusuf S, Kober L, et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet 2000;355:1575-81.
11. Clarke KW, Gray D, Hampton JR. Evidence of inadequate investigation and treatment of patients with heart failure. British Heart Journal 1994;71:584-7.
12. Fuat A, Hungin AP, Murphy JJ. Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study. BMJ 2003;326:196.
13. Khunti K, Hearnshaw H, Baker R, et al. Heart failure in primary care: qualitative study of current management and perceived obstacles to evidence-based diagnosis and management by general practitioners. Eur J Heart Fail 2002;4:771-7.
14. McAlister FA, Lawson FME, Teo KK, et al. Randomised trials of secondary prevention programmes in coronary heart disease: Systematic review. BMJ 2001;323:957-62.
15. Whellan DJM. Metaanalysis and review of heart failure disease management randomized controlled clinical trials. Am Heart J 2005;149:722-9.
16. Gonseth J, Guallar-Castillon P, Banegas JR, et al. The effectiveness of disease management programmes in reducing hospital re-admission in older patients with heart failure: a systematic review and meta-analysis of published reports. Eur Heart J 2004;25:1570-95.
17. Roccaforte R, Demers C, Baldassarre F, et al. Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A meta-analysis. Eur J Heart Fail 2005;7:1133-44.
18. Bruggink-Andre de la Porte PW, Lok DJ, van Wijngaarden J, et al. Heart failure programmes in countries with a primary care-based health care system. Are additional trials necessary? Design of the DEAL-HF study. Eur J Heart Fail 2005;7:910-20.
19. Davies MK, Hobbs FDR, Davis RC, et al. Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: A population based study. Lancet 2001;358:439-44.
20. Khunti K, Baker R, Grimshaw G. Diagnosis of patients with chronic heart failure in primary care: usefulness of history, examination, and investigations. British Journal of General Practice 2000;50:50-4.
21. Wood D, Durrington P, Poulter N, et al. Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart (British Cardiac Society) 1998;80(Suppl 2):S1-29.
22. Anonymous. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. Eur Heart J 1998;19:1434-503.
23. Scottish Intercollegiate Guidelines Network. Diagnosis and treatment of heart failure due to left ventricular systolic dysfunction. Report No. 35. Edinburgh: SIGN, 1999.
24. Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:1115- 40.
25. Garratt AM, Ruta DA, Abdalla MI, et al. The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? BMJ 1993;306:1440-4.
26. Spertus JA, Winder JA, Dewhurst TA, et al. Development and evaluation of the Seattle Angina Questionnaire: A new functional status measure for coronary artery disease. Journal of the American College of Cardiology 1995;25:333-41.
27. O'Leary CJ, Jones PW. The left ventricular dysfunction questionnaire (LVD-36): Reliability, validity, and responsiveness. Heart 2000;83:634-40.
28. Feder G, Griffiths C, Eldridge S, et al. Effect of postal prompts to patients and general practitioners on the quality of primary care after a coronary event (POST): randomised controlled trial. BMJ 1999;318:1522-6.
29. Campbell NC, Ritchie LD, Thain J, et al. Secondary prevention in coronary heart disease: a randomised trial of nurse led clinics in primary care. Heart 1998;80:447-52.
30. Wilson S, Delaney BC, Roalfe A, et al. Randomised controlled trials in primary care: case study. BMJ 2000;321:24-7.
31. Rutten FH, Moons KG, Cramer MJ, et al. Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study. BMJ 2005;331: 1379.
32. Blue L, Lang E, McMurray JJV, et al. Randomised controlled trial of specialist nurse intervention in heart failure. BMJ 2001;323:715-8.
33. McAlister FA, Teo KK, Taher M, et al. Insights into the contemporary epidemiology and outpatient management of congestive heart failure. Am Heart J 1999;138:87-94.
34. Campbell NC. Secondary prevention clinics: improving quality of life and outcome. Heart, 2004;90(Suppl IV), 29-32.
35. Jolly K, Bradley F, Sharp S, et al. Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: final results of the Southampton heart integrated care project (SHIP). The SHIP Collaborative Group. BMJ 1999;318:706-11.
36. Galbreath AD, Krasuski RA, Smith B, et al. Long-term healthcare and cost outcomes of disease management in a large, randomized, community-based population with heart failure. Circulation 2004;110:3518-26.
37. McAlister FA, Murphy NF, Simpson CR, et al. Influence of socioeconomic deprivation on the primary care burden and treatment of patients with a diagnosis of heart failure in general practice in Scotland: population based study. BMJ 2004;328:1110.
38. Komajda M, Follath F, Swedberg K, et al. The EuroHeart Failure survey programme: A survey on the quality of care among patients with heart failure in Europe. Part 2: Treatment. Eur Heart J 2003;24:464-74.
39. Ekman I, Andersson B, Ehnfors M, et al. Feasibility of a nurse-monitored, outpatient-care programme for elderly patients with moderate-to-severe, chronic heart failure. Eur Heart J 1998;19:1254-60.
40. Mejhert M, Kahan T, Persson H, et al. Limited long term effects of a management programme for heart failure. Heart 2004;90:1010-5.
41. Doughty RN, Wright SP, Pearl A, et al. Randomized, controlled trial of integrated heart failure management: The Auckland Heart Failure Management Study. Eur Heart J 2002;23:139-46.
42. Stromberg A, Martensson J, Fridlund B, et al. Nurse-led heart failure clinics in Sweden. Eur J Heart Fail 2001;3:139-44.
43. Krumholz HMM, AHA/ACC Conference. Evaluating quality of care for patients with heart failure. Circulation 2000;101:e122-40.